Xu H[Author] - Search Results

Year	Number of Results
1979	2
1980	6
1981	6
1982	7
1983	9
1984	9
1985	17
1986	11
1987	18
1988	22
1989	29
1990	43
1991	48
1992	63
1993	66
1994	86
1995	83
1996	74
1997	72
1998	109
1999	100
2000	153
2001	184
2002	255
2003	300
2004	374
2005	438
2006	521
2007	633
2008	760
2009	844
2010	1097
2011	1173
2012	1435
2013	1647
2014	1906
2015	2179
2016	2266
2017	2427
2018	2795
2019	3386
2020	3964
2021	900

1

Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies.

Wang S, Zhang K, Tan S, Xin J, Yuan Q, Xu H, Xu X, Liang Q, Christiani DC, Wang M, Liu L, Du M. Wang S, et al. Among authors: xu h. Mol Cancer. 2021 Jan 11;20(1):13. doi: 10.1186/s12943-020-01298-z. Mol Cancer. 2021. PMID: 33430880 Free PMC article. Review.

2

Regulation of Autophagy by Glycolysis in Cancer.

Chu Y, Chang Y, Lu W, Sheng X, Wang S, Xu H, Ma J. Chu Y, et al. Among authors: xu h. Cancer Manag Res. 2020 Dec 23;12:13259-13271. doi: 10.2147/CMAR.S279672. eCollection 2020. Cancer Manag Res. 2020. PMID: 33380833 Free PMC article. Review.

3

Engineering Prodrug Nanomedicine for Cancer Immunotherapy.

Yang B, Gao J, Pei Q, Xu H, Yu H. Yang B, et al. Among authors: xu h. Adv Sci (Weinh). 2020 Oct 25;7(23):2002365. doi: 10.1002/advs.202002365. eCollection 2020 Dec. Adv Sci (Weinh). 2020. PMID: 33304763 Free PMC article. Review.

4

Application of Inorganic Nanocomposite Hydrogels in Bone Tissue Engineering.

Han X, Xu H, Che L, Sha D, Huang C, Meng T, Song D. Han X, et al. Among authors: xu h. iScience. 2020 Nov 23;23(12):101845. doi: 10.1016/j.isci.2020.101845. eCollection 2020 Dec 18. iScience. 2020. PMID: 33305193 Free PMC article. Review.

5

Tailored Interventions to Improve Medication Adherence for Cardiovascular Diseases.

Xu HY, Yu YJ, Zhang QH, Hu HY, Li M. Xu HY, et al. Front Pharmacol. 2020 Nov 13;11:510339. doi: 10.3389/fphar.2020.510339. eCollection 2020. Front Pharmacol. 2020. PMID: 33364935 Free PMC article. Review.

6

A CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals essential and non-essential modes of oncogenic transformation.

Lo YH, Kolahi KS, Du Y, Chang CY, Krokhotin A, Nair A, Sobba WD, Karlsson K, Jones SJ, Longacre TA, Mah AT, Tercan B, Sockell A, Xu H, Seoane JA, Chen J, Shmulevich I, Weissman JS, Curtis C, Califano A, Fu H, Crabtree GR, Kuo CJ. Lo YH, et al. Among authors: xu h. Cancer Discov. 2021 Jan 15:candisc.1109.2020. doi: 10.1158/2159-8290.CD-20-1109. Online ahead of print. Cancer Discov. 2021. PMID: 33451982 Free article.

7

Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.

Fu LH, Wan Y, Qi C, He J, Li C, Yang C, Xu H, Lin J, Huang P. Fu LH, et al. Among authors: xu h. Adv Mater. 2021 Feb;33(7):e2006892. doi: 10.1002/adma.202006892. Epub 2021 Jan 4. Adv Mater. 2021. PMID: 33394515

8

Müller Glia-Mediated Retinal Regeneration.

Gao H, A L, Huang X, Chen X, Xu H. Gao H, et al. Among authors: xu h. Mol Neurobiol. 2021 Jan 8. doi: 10.1007/s12035-020-02274-w. Online ahead of print. Mol Neurobiol. 2021. PMID: 33417229 Review.

9

Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases.

Xu HK, Chen LJ, Zhou SN, Li YF, Xiang C. Xu HK, et al. World J Stem Cells. 2020 Nov 26;12(11):1276-1294. doi: 10.4252/wjsc.v12.i11.1276. World J Stem Cells. 2020. PMID: 33312398 Free PMC article. Review.

10

The complete chloroplast genome sequence of Prunus sibirica.

Dong S, Zhang X, Sun Y, Xu H, Zhang H, Chen J, Liu M. Dong S, et al. Among authors: xu h. Mitochondrial DNA B Resour. 2020 Jan 14;5(1):581-582. doi: 10.1080/23802359.2019.1710589. Mitochondrial DNA B Resour. 2020. PMID: 33366656 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results